Introduction
The United Nations High Commissioner for Refugees (UNHCR) reported that by the end of 2016, 65.6 million people worldwide were forcibly displaced due to conflict, violence or human rights violations 1 ; a record high figure. Of these people, 40.3 million were forcibly displaced within their own country meaning that internally displaced people (IDPs) constitute approximately two-thirds of all displaced people worldwide. In Ukraine, specifically, there are currently 1.8 million IDPs, equating to a rate of 100 per 1000 of the population 1 . Internally displaced peoples are commonly exposed to multiple traumatic life events including war, sexual and physical violence, torture, and witnessing death and extreme human suffering 1 . Recognizing the immensely deleterious mental health effects of forced displacement for such a large proportion of the world's population, the World Bank and the World Health Organization (WHO) recently issued a joint call for the prioritization of mental health as a key component of the global health agenda 2 . The American Psychiatric Association (APA) 3 and the WHO 4 have recently revised their formulation of post-traumatic stress disorder (PTSD); a psychiatric disorder commonly observed in forcibly displaced people 5 . The fifth edition of the APA's Diagnostic and Statistical Manual of Mental Disorders (DSM-5) includes 20 symptoms of PTSD that are organized under four symptom clusters; intrusions, avoidance, negative alternations in cognitions and mood (NACM), and alternations in arousal and reactivity (AR). A diagnosis of PTSD requires exposure to a Criterion A stressor and the endorsement of at least one intrusion symptom, one avoidance symptom, two NACM symptoms and two AR symptoms. Additionally, these symptoms must be associated with functional impairment, and be present for more than one month. The proposed model of PTSD set forth for the 11th version of the International Classification of Diseases (ICD-11) published by the WHO includes six symptoms organized under three symptom clusters; re-experiencing of the traumatic event(s) in the here and now (Re), avoidance of traumatic reminders (Av) and a sense of current threat (Th). A diagnosis of PTSD requires exposure to an extreme stressor and the endorsement of at least one symptom from each cluster. Additionally, symptoms must be associated with functional impairment and be present for several weeks.
The ICD-11 proposals for a reduced set of PTSD symptoms were based on the desire to (i) simplify the assessment of PTSD to enhance clinical utility, particularly in low-resourced and/ or humanitarian crisis contexts, (ii) reduce the high level of symptom profile heterogeneity and (iii) reduce the comorbidity with other disorders 4 . The simplification of assessment and diagnosis is clearly achieved with a much reduced symptom set. Galatzer-Levy and Bryant 6 showed that for DSM-5 PTSD, there are 636 120 different possible symptom combinations for a diagnosis. Applying the same methods to ICD-11 PTSD, there are only 27 possible symptom combinations for a diagnosis. Whether the ICD-11 model of PTSD reduces comorbidity with other disorders is unclear due to the limited number of studies. O'Donnell et al. 7 reported that in a sample of 953 injury patients, DSM-5 PTSD was associated with an 11% higher comorbidity rate with depression as compared to ICD-11, although this difference was not statistically significant. Hafstad et al. 8 reported that for parents of young survivors of the 2011 Norway attacks (n = 451), ICD-11 PTSD was associated with higher levels of anxiety and depression comorbidity compared to DSM-5 PTSD, but this difference was not significant.
Studies that have examined differences in prevalence rates between the two diagnostic criteria have been somewhat mixed. Significantly higher rates of DSM-5 PTSD have been reported amongst physical injury patients in Australia 7 , adult survivors of childhood sexual abuse in Denmark 9 , community and veteran samples in the United States 10 , motor vehicle and incest survivors in Denmark 11 and treatment-seeking patients in Scotland 12 . In contrast, Stein et al. 13 found no difference between DSM-5 and ICD-11 PTSD based on pooled crossnational data from 23 936 community participants. Likewise, Hansen et al. 11 reported no significant differences in PTSD prevalence in five Danish samples (bereaved parents, paraplegics, physical assault victims, sexual assault victims and help-seeking trauma patients).
The main limitation of existing research comparing DSM-5 and ICD-11 PTSD prevalence and comorbidity is that, with the exception of one study 12 , a standardized and validated measure of ICD-11 PTSD has not been utilized. To date, ICD-11 PTSD has generally been assessed using a subset of symptom indicators originally developed to measure DSM-based symptoms (DSM-IV or DSM-5). Given that the specific symptom content of ICD-11 PTSD does not correspond precisely to the DSM-based symptoms, the existing estimates of prevalence and comorbidity across the two criteria may be misleading. A disorder-specific measure of ICD-11 PTSD (and Complex PTSD), the International Trauma Questionnaire (ITQ) 14 , was recently developed and validated 15, 16 . It is important that any assessment of prevalence rates and comorbidity of ICD-11 PTSD be based on an instrument that accurately measures the ICD-11 PTSD symptom content and therefore acknowledges the important differences between the ICD-11 and DSM-5 symptom criteria. In particular, the ICD-11 emphasizes re-experiencing of the traumatic event 'in the here and now' as an essential feature of PTSD; a distinction that is often not captured by proxy-measures designed for DSM-IV or DSM-5 PTSD. Several studies have suggested that differences between DSM-5 and ICD-11 PTSD diagnostic rates are attributable to differences in the proportion of individuals meeting this criterion 8, 9 . Another limitation of the extant research is the use of non-representative, opportunistic samples; to date, there has been no evaluation of ICD-11 and DSM-5 prevalence and comorbidity rates based on large probability-based samples; or amongst IDPs.
The primary aim of this study was to compare ICD-11 (using the ITQ) and DSM-5 (using the PCL-5) PTSD prevalence and comorbidity rates, in a large, representative sample of Ukrainian adult IDPs. On the basis that (i) this study is the first to assess prevalence and comorbidity rates amongst an IDP sample; (ii) the scant evidence regarding comorbidity across the two criteria; and (iii) the inconsistent findings regarding prevalence estimates of DSM-5 versus ICD-11 PTSD, no formal hypotheses were formulated. Rather, we investigated four study aims:
i To determine the prevalence rates, and gender differences, of DSM-5 and ICD-11 PTSD amongst a representative sample of adult Ukrainian IDPs. Additionally, we sought to identify individual's that represented 'unique' cases of DSM-5 PTSD (i.e. those that meet the diagnostic criteria for DSM-5 but not ICD-11 PTSD) and 'unique' cases of ICD-11 PTSD (i.e. those that meet the diagnostic criteria for ICD-11 but not DSM-5 PTSD). ii To determine whether there are differences in levels of disability amongst IDPs that meet diagnostic status for DSM-5 and ICD-11 PTSD. Differences in levels of disability were also compared across 'unique' DSM-5 and ICD-11 PTSD cases. iii To determine the degree of comorbidity for ICD-11 and DSM-5 PTSD with Generalized Anxiety Disorder (GAD), Major Depressive Disorder (MDD) and combined GAD and MDD. Comorbidity rates for 'unique' ICD-11 and DSM-5 PTSD cases were also assessed.
iv To determine whether specific types of trauma are differentially associated with ICD-11 and DSM-5 PTSD. The association between specific trauma types and a 'unique' ICD-11 PTSD diagnosis, as compared to a 'unique' DSM-5 PTSD diagnosis, was also assessed.
Methods

Participants
Data come from the 'Internally Displaced Person's Mental Health' survey that was carried out from March to May 2016 all over Ukraine excluding occupied territories 17 . The survey covered all oblasts of Ukraine and 74 settlements (mainly urban). Time-location sampling was chosen as a probabilistic method to recruit hard-to-reach and migrant populations 18 . In total, 121 unique locations were used for recruitment during the survey: 33.0% from collective centres, 31.0% from NGOs that work with IDPs, 6.0% from state institutions, 24.0% were recruited with the help of another person (informant), and 6.0% were reached by other means. A weighting variable was calculated to correct the regional structure of the sample in accordance with official statistics and was applied for all analyses.
The sample (N = 2198) includes male and female IDPs (91.8% had official IDP status with the UNHCR) who live both in institutional and noninstitutional settings on the territories controlled by the Ukrainian government. Following agreed definitions for IDPs 19 , a person in this study was considered an IDP if they answered 'yes' to the screening question that they had been forced to flee their home because of conflict and were currently living away from their home. Exclusion criteria included people deemed under the influence of alcohol or drugs, and those with severe intellectual or mental impairment, at the time of the survey. Data collectors were trained in the identification of these predetermined exclusion criteria which related to criteria of understanding, expression, communication and behaviour. The mean time since displacement was 17.49 months (SD = 4.49). The sample included 1496 (68.1%) females, and the mean age was 45 years (SD = 16.99). The majority of participants reported being married or cohabiting (52.7%), 20.2% were single, 14.3% were divorced, and 12.8% were widowed. Most participants had completed higher education (35.9%) or secondary technical education (29.5%) with the remaining having lower levels of educational attainment. Most participants who were working were in regular paid work (22.4%) with others in irregular paid work (9.9%) or selfemployed (2.8%); 28.9% were retired due to oldage or invalidity, and 17.9% were unemployed and seeking work. The remaining participants (18.1%) were doing voluntary work, students, homemakers or on maternity leave.
The questionnaires were completed through face-to-face interviews in either Ukrainian or Russian by trained enumerators from the Kiev International Institute of Sociology (KIIS) in a private space chosen by the respondent. Before administering the questionnaire, each respondent listened to the explanations about the aim of the survey and terms of participation. In addition, the participant received an information sheet and consent form and then gave either written or verbal consent. Ethical approval was provided by the KIIS Institutional Review Board. All team leaders of regional groups of interviewers were instructed and trained before the survey, and the team leaders provided the training to their teams of experienced data collectors. The response rate of IDPs was around 90% in the whole sample.
Measures
Icd-11 ptsd. The ITQ 14 is a preliminary stage, selfreport measure of ICD-11 PTSD (and Complex PTSD) symptomatology. Six items represent the three clusters of PTSD (Re, Av, Th) using two items each. An additional three items measure functional impairment associated with these symptoms (e.g. impairment in (i) social, (ii) occupational and (iii) parenting or other important activities). All items are answered on a five-point Likert scale anchored by 'Not at all' (0) and 'Extremely' (iv). Diagnostic criteria require a score of ≥2 ('Moderately') for at least one symptom from each cluster, along with endorsement of at least one functional impairment item. Amongst the current IDP sample, the reliability of the total scale (a = 0.89) and the Re (a = 0.86), Av (a = 0.75) and Th (a = 0.81) subscales were good.
20 is a 20-item, self-report measure capturing each DSM-5 PTSD symptom. Participants respond using the same 5-point Likert scale as the ITQ. Diagnostic criteria require a score of ≥2 ('Moderately') for at least one intrusion symptom, one avoidance symptom, two NACM symptoms and two arousal symptoms. Endorsement of at least one functional impairment item is also required (the PCL-5 and ITQ use the same functional impairment items). The PCL-5 has demonstrated acceptable reliability and validity in previous studies 21 . Amongst the current sample, the reliability of the total scale (a = 0.96) and the intrusions (a = 0.89), avoidance (a = 0.88), NACM (a = 0.90) and AR (a = 0.89) subscales were good.
Lifetime traumatic exposure
The life events checklist (LEC) 22 is a 17-item, selfreport measure screening for lifetime traumatic exposures. The LEC assesses lifetime exposure to 16 traumas plus one open question for respondents to indicate any other traumatic event not listed. The overwhelming majority of respondents indicated exposure to at least one traumatic life event (93.3%, n = 2051), and the most commonly reported trauma was exposure to war or combat (71.3%, n = 1566). For each item, the respondent checks whether the event 'Happened to me' (i), 'Witnessed it happening to somebody else' (ii), 'Learned about it happening to someone close to me' (iii), 'Part of my job' (iv), 'Not sure it applies' (v), 'Doesn't apply to my experience' (vi). The scores were recoded into binary variables with 'Happened to me' responses being coded as 1 and all other responses coded as 0, except for the 'Sudden violent death' and 'Sudden accidental death' items which were coded 1 for 'Witnessed it happening to somebody else' and all other responses coded as 0.
Measures of psychiatric comorbidity
The Generalized Anxiety Disorder Scale (GAD-7)
23 is a 7-item, self-report measure assessing each DSM-IV symptom of GAD. The instructions state, 'Over the last 2 weeks, how often have you been bothered by any of the following problems?' and participants respond using a 4-point Likert scale ['Not at all' (0) to 'nearly every day' (3)]. Total scores on the GAD-7 range from 0 to 21. Scores ≥10 are used as a cut-off to identify diagnosis of GAD 24 . The reliability of the scale in this sample was high (a = 0.93).
The Patient Health Questionnaire-Depression (PHQ-9) 25 is a 9-item, self-report measure assessing each DSM-IV symptom of MDD. Instructions and response options are the same as the GAD-7. Total scores range from 0 to 27. Scores ≥10 are used as a cut-off to identify diagnosis of MDD 25 . The reliability of the scale in this sample was high (a = 0.91).
Disability
The WHO Disability Assessment Schedule 2.0 (WHODAS 2.0) 26 is a 12-item self-report measure that assesses activity limitations and participation restrictions in six domains (Understanding and communicating, Mobility, Self-care, Social functioning, Household activities, Community activities). The instructions state, "In the last 30 days how much difficulty did you have in. . .", and participants respond to each item using a 5-point Likert scale ranging from 'None' (0) to 'Extreme or cannot do' (4). Total scores range from 0 to 48 with higher scores reflecting greater levels of disability. No agreed upon cut-off score exists for the WHODAS 2.0; however, scores ≥10 have been shown to include the top 10% of the population distribution of WHODAS 2.0 scores and therefore likely to reflect those with clinically relevant levels of disability 27 . Consistent with previous PTSD-based studies 8 , a score ≥10 was used in this study to identify individuals with 'clinically significant levels of disability'. The reliability of the scale in this sample was high (a = 0.94).
The survey questionnaire was largely developed in English and then underwent a thorough adaptation and translation process into Ukrainian and Russian based on best practise procedures to help ensure reliability, validity and appropriateness with the study population. This included the following: (i) translation from English into Ukrainian and Russian using professional translators, with translations reviewed by mental health experts individually and then as a group for cultural relevance, content and concept consistency, clarity and understanding; (ii) a back translation to check for accuracy, consistency and equivalence, with adjustments made accordingly; and (iii) piloting and field testing a to refine the instruments further 28 . Ukrainian and Russian versions of the PCL-5, PHQ-9 and LEC-5 instruments were used as they already existed but were still subject to the back translation and expert discussion.
Analysis
The prevalence rates were estimated using the weighted frequencies (and percentages) with 95% confidence intervals, and group comparisons were conducted using the exact McNemar binomial test. Differences in percentages were expressed as 'percentage change' [(% 1 À % 2 )/(% 1 ) 9 100]. The reliability of all self-report scales was assessed using Cronbach's alpha. The associations between trauma exposure and diagnostic status were estimated using binary logistic regression.
Results
Prevalence rates
The prevalence of DSM-5 PTSD was 27.4% (95% CI = 25.52-29.33%), while the prevalence of ICD-11 PTSD was 21.0% (95% CI = 19.18-22.65%); representing an increase of 30.5% in diagnostic rates under DSM-5 (see Table 1 ). This difference in diagnostic rates according to the two criteria was statistically significant (exact binomial test: P < 0.001). There were a larger number of 'unique' DSM-5 PTSD cases (9.6%, n = 197) than 'unique' ICD-11 PTSD cases (3.5%, n = 71). Additionally, 17.6% (n = 362) of IDPs met the diagnostic criteria for both DSM-5 and ICD-11 PTSD; a level of diagnostic agreement that was considered to be 'substantial' 29 (k = 0.64, SE = 0.02, P < 0.001). DSM-5 PTSD rates were significantly higher for females (31.1%; 95% CI = 29.05-33.92%) than males (19.6%; 95% CI = 16.29-22.33%) representing an increase of 58.1%. ICD-11 PTSD rates were also significantly higher for females (24.6%; 95% CI = 22.57-27.11%) than males (13.1%; 95% CI = 10.46-15.61%) representing an increase of 87.8% (see Table 1 ).
The difference in PTSD prevalence across the two diagnostic systems is primarily due to variation in the proportion of IDPs that meet the respective 'Intrusions' (DSM-5: 71.5%) and 'Reexperiencing' (ICD-11: 31.9%) symptom criteria. The proportion of individuals meeting criteria for Avoidance (DSM-5 = 54.1%, ICD-11 = 51.0%) and Arousal (DSM-5: 39.1%) and Sense of Threat (ICD-11: 40.2%) was concordant.
Disability and comorbidity rates
Amongst those with a DSM-5 PTSD diagnosis, 48.5% experienced clinically significant levels of , chi-square test; df, degrees of freedom; P, level of statistical significance. The piloting was conducted with approximately 30 IDPs in Kiev who were not included in the main survey conducted later on. The piloting sought to assess the (i) clarity, comprehension, comprehensiveness of the questionnaire, (ii) understanding of the consent procedures, (iii) feasibility (e.g. questionnaire administration time, respondent willingness to participate), (iv) potential for respondent burden and distress, (v) socio-cultural appropriateness and (vi) formatting of the questionnaire (e.g. skip patterns, ordering of the questions). Any key findings were noted by data collectors. They also asked participants about the survey instrument and any comments they had on it (based on the criteria noted above). The findings were then shared with the management team and discussed and alterations made where appropriate.
disability, and 57.6% of those with an ICD-11 PTSD diagnosis experienced clinically significant levels of disability. 'Unique' ICD-11 PTSD was associated with significantly higher levels of disability compared to 'unique' DSM-5 PTSD (36.7% vs. 28.6%, exact binomial test: P < 0.001).
Based on the GAD-7, 16.1% of participants met the criteria for GAD, and based on the PHQ-9, 20.6% of the participants met the criteria for MDD; 10.8% met the criteria for both GAD and MDD. The rates of comorbidity of PTSD with GAD, MDD and combined GAD and MDD, respectively, were all higher for ICD-11 PTSD than DSM-5 PTSD. For 'unique' cases of PTSD, comorbidity rates with GAD, and combined GAD and MDD, were significantly higher for ICD-11 PTSD, whereas comorbidity with MDD was significantly higher for DSM-5 PTSD (Table 2 ).
PTSD and traumatic exposure
A series of bivariate binary logistic regression models was tested. Each trauma from the LEC was used as a predictor variable, and the ICD-11 and DSM-5 diagnoses were used as criterion variables (see Table 3 ). Most traumatic experiences were significantly related to a DSM-5 PTSD diagnosis, except for 'exposure to a war zone' and 'captivity'. The largest effects were for 'serious injury, harm or death you caused to someone else' (OR = 3.00), 'sexual assault' (OR = 2.95) and 'life-threatening illness or injury' (OR = 2.59). Most traumatic experiences were also significantly related to ICD-11 PTSD, except for 'captivity'. The largest effects were for 'sexual assault' (OR = 3.66), 'other unwanted or uncomfortable sexual experience' (OR = 3.28) and 'serious injury, harm or death you caused to someone else' (OR = 2.80).
Finally, a series of bivariate binary logistic regression analyses was conducted to determine the association between each trauma from the LEC and a 'unique' ICD-11 PTSD diagnosis (the 'unique' DSM-5 PTSD diagnosis group were used as the reference category for these analyses). As detailed in Table 3 , one traumatic event, 'severe human suffering', was significantly related to an elevated risk of 'unique' ICD-11 PTSD (OR = 1.76). Exposure to a 'transportation accident' was significantly related to a reduced risk of 'unique' ICD-11 PTSD (OR = 0.22).
Discussion
The primary objective of the current study was to provide the first methodologically rigorous assessment of the prevalence and comorbidity rates of ICD-11 and DSM-5 PTSD in a large, representative sample of internally displaced Ukrainian adults. The first aim of the study was to determine whether prevalence rates of PTSD varied significantly across the two diagnostic systems and we found that DSM-5 was associated with 30.5% more diagnostic cases. Although the reported level of Kapp (0.64) is described as 'substantial' according to Cohen's criteria, it represents a level of agreement that is lower than expected for two measures that purportedly measure the same construct. More context-specific interpretations of kappa have been proposed by McHugh 29 who suggested that levels of agreement over 0.80 are more appropriate in clinical research. These findings are consistent with a number of studies that have reported significantly lower rates of PTSD for ICD-11 compared to DSM-5 [8] [9] [10] [11] [12] . Furthermore, as in prior studies 8, 9 , the significantly lower rates of ICD-11 PTSD were largely attributable to fewer individuals satisfying the newly proposed 're-experiencing' criteria. The stipulation of re-experiencing the traumatic event in the here and now for ICD-11 may represent a less common psychological reaction as compared to other forms of re-experiencing that are included within the DSM-5 (e.g. becoming upset upon reminders of a trauma). The focus on present-moment re-experiencing may result in the ICD-11 diagnosis being more 'difficult' to attain, that is, a person requires a more intense and distressing reliving of the trauma before meeting the diagnostic criteria. Another possibility is that the broader nature of DSM-5 PTSD, with the inclusion of multiple non-trauma specific symptoms, can result in an 'easier' PTSD diagnosis. If one considers that the psychological response to trauma can be represented as an underlying continuum of distress severity, then the threshold for a DSM-5 diagnosis lies lower on the continuum than an ICD-11 diagnosis.
This conclusion is supported by the results of the association between PTSD status and disability. A significantly greater number of individuals who met diagnosis under ICD-11, compared to DSM-5, exhibited clinically meaningful levels of disability. The same pattern of results was also identified when unique cases of ICD-11 and DSM-5 PTSD were compared. Although a PTSD diagnosis according to both the DSM-5 and the ICD-11 identified a substantial number of people with high levels of impairment in daily functioning, it appears that the ICD-11 diagnosis, in particular, is sensitive at capturing individuals experiencing clinically significant levels of disability. The study's second aim was to assess whether significant gender differences existed in PTSD prevalence for DSM-5 and ICD-11 PTSD. For the ICD-11 diagnosis, the rate for females was almost double that for males, and for DSM-5, the increase was approximately one-third. This is consistent with the plethora of research that has identified significant gender differences 30 , but the difference in prevalence based on the DSM-5 was smaller than the 2:1 ratio that has been reported in population-based studies 31 . Although PTSD prevalence was common amongst this sample of Ukrainian IDPs, irrespective of which diagnostic systems were selected, the level of diagnostic agreement between the two systems was quite low. Only 17.6% of IDPs were diagnosed with PTSD according to both the ICD-11 and DSM-5 diagnostic algorithms. A substantial number of IDPs qualified for a diagnosis of PTSD according to the DSM-5 but not the ICD-11 (9.6%), while a smaller number qualified for a diagnosis of PTSD according to the ICD-11 but not the DSM-5 (3.5%). This demonstrates that there are a considerable number of trauma survivors who will only meet diagnostic status under one of the two available criteria. This circumstance has been highlighted as a challenge to the field of psychotraumatology as victims of trauma, and their caregivers, may be denied compensation and/or insurance coverage depending upon which diagnostic system is selected 32 . Regrettably, this set of affairs is likely to persist into the near future and until there is an agreed-upon diagnostic model of PTSD.
The third aim of this study was to assess the degree of comorbidity for ICD-11 and DSM-5 PTSD with GAD, MDD and combined GAD and MDD. The ICD-11 proposals for a reduced symptom set related to 'core' PTSD symptoms were, in part, aimed at reducing the high levels of comorbidity that have been reported, particularly with other mood and anxiety disorders 33 . However, contrary to this proposition, significantly higher levels of comorbidity with GAD (7.9%), MDD (6.5%) and combined GAD and MDD (8.1%) were associated with ICD-11 PTSD, not DSM-5 PTSD. An interesting pattern of comorbidity emerged when unique ICD-11 and DSM-5 PTSD cases were compared. The unique ICD-11 PTSD cases were associated with higher comorbidity rates for GAD and combined GAD and MDD, whereas unique cases of DSM-5 PTSD were associated with higher comorbidity rates for MDD. These findings suggest that ICD-11 PTSD shares more in common with anxiety disorders, while DSM-5 shares more in common with depressive disorders. These findings are congruent with theoretical proposals 4 and prior empirical results
7
. The high levels of comorbidity, and the specific patterns of comorbidity, are difficult to interpret within a traditional categorical model of psychopathology where a focus on unique symptoms rather than trans-diagnostic symptoms should reduce comorbidity. However, these findings do make sense within a dimensional model of psychopathology. Recently, Kotov et al. 33 proposed the 'Hierarchical Taxonomy of Psychopathology' (HiTOP) model that is based on an abundance of empirical data indicating that psychiatric disorders cluster into meaningful superordinate latent factors (e.g. dimensions of 'Internalizing', 'Externalizing' and 'Thought Disorder') [34] [35] [36] . The HiTOP model considers diagnoses such as PTSD, GAD and MDD as 'syndromes' occurring under the 'Distress' factor; a subfactor subsumed by a superordinate 'Internalizing' psychopathology dimension. This hierarchical model assumes a causal system similar to the factor analytic or 'effect' indicator model 37 which posit downward causal effects. This means that increased levels of Internalizing psychopathology will increase the likelihood of higher levels of the 'Distress' subfactor which will consequently result in increased scores in all of its 'indicators' (i.e. syndromes) such PTSD, GAD and MDD. In other words, under the assumption of a dimensional model of psychopathology, high levels of comorbidity between PTSD, GAD and MDD are unavoidable given their shared relationship to an underlying latent variable (Internalizing). Furthermore, as in factor analytic models, when 'indicators' (e.g. PTSD) are measured with greater precision and less error (e.g. by focusing on 'core symptoms'), the observed covariation with other indicators (e.g. GAD, MDD) will inevitably increase. The objective of the revision to ICD-11 PTSD to reduce comorbidity with other 'Internalizing' disorders through a focus on core symptoms may therefore be unachievable given the assumptions associated with a categorical model of psychopathology.
There are two other factors that may help to explain the observed comorbidity rates. First, it is likely that exposure to traumatic stressors is an aetiological risk factor not just for PTSD, but also for many other psychiatric conditions including depression and anxiety. As the ICD-11 model of PTSD reflects a more 'specific' disorder than DSM-5 PTSD, it is important that clinicians screen for other conditions such as GAD and MDD amongst trauma-exposed persons when adopting the use of the ICD-11 model of PTSD. Secondly, the current findings suggest that ICD-11 PTSD also represents a more 'severe' psychiatric disorder than DSM-5 PTSD. Consequently, an increased likelihood of diagnostic comorbidity associated with ICD-11 PTSD may be precisely what one should expect to observe.
The study's fourth objective sought to determine whether there are specific types of trauma that are differentially associated with ICD-11 and DSM-5 PTSD. When examining the relative relationships between each trauma type and risk of DSM-5 or ICD-11 PTSD, the traumatic events that were more strongly associated with ICD-11 PTSD included sexual assault, unwanted sexual contact, exposure to war and exposure to severe human suffering; traumatic events that are widely recognized as the most distressing/impairing 38 . Furthermore, exposure to severe human suffering was found to significantly increase the likelihood of having a 'unique' ICD-11 PTSD diagnosis compared to a 'unique' DSM-5 PTSD diagnosis, whereas exposure to a transportation accident was found to decrease the likelihood of having a 'unique' ICD-11 PTSD diagnosis. Here, again evidence was found to suggest that ICD-11 PTSD may be associated with increased scores on an underlying distress continuum.
Several limitations associated with the current study should be recognized. While the representative nature of the current sample is a key strength, the current findings may not generalize to IDP populations in culturally distinct contexts. The use of self-report measures to estimate prevalence and comorbidity rates may be considered suboptimal as compared to the use of diagnostic interviews. It is possible therefore that estimates of the prevalence and comorbidity may be somewhat overestimated. However, for the purposes of the current study where we sought to compare DSM-5 and ICD-11 prevalence, and their comorbidity with GAD and MDD, this limitation was constant across all analyses meaning that current results are interpretable. Finally, it was not possible to assess comorbidity rates with disorders reflecting the 'Externalizing' and 'Thought Disorder' dimensions of psychopathology. It is possible that differences in comorbidity rates for ICD-11 and DSM-5 could vary depending upon which disorders are selected. Future research should therefore seek to estimate comorbidity with disorders reflecting traditional Externalizing psychopathology (e.g. addiction) and Thought Disorder psychopathology (e.g. schizophrenia).
To conclude a fundamental goal of the ICD-11 is that diagnoses be cross-culturally relevant, particularly within low-resourced and/or humanitarian crisis situations. The current findings with Ukrainian IDPs provide initial evidence that the ICD-11 diagnosis of PTSD is meaningful in such a context. Our findings have important implications for clinicians working with IDPs. The ICD-11 diagnosis of PTSD is particularly helpful at detecting individuals experiencing higher levels of psychiatric distress and disability and therefore those in the greatest need of clinical intervention. The ICD-11 model may therefore be considered optimal in humanitarian contexts where clinical resources are limited. However, clinicians should also be aware that the ICD-11 criteria will likely yield fewer diagnostic cases of PTSD compared to the DSM-5 criteria and should therefore screen for other psychiatric disorders that are common posttrauma.
